The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Emerging multidrug-resistant Candida species
Abstract
Purpose of review: To describe the epidemiology, strategies for early detection, and clinical management of infections caused by the most commonly found multidrug-resistant (MDR)Candida spp. Recent findings: Increasing numbers of reports describing invasive infections by MDR Candida auris and Candida glabrata has been reported in medical centers worldwide. Summary: We checked all papers published along the last 10 years describing epidemiological, diagnostic, and clinical aspects of infections by MDR Candida spp., with emphasis on C. auris and C. glabrata spp.C. auris has been reported in 15 countries and multidrug resistance rates is usually above 30%. Horizontal transmission is a great concern regarding C. auris.C. glabrata ranks the second most reported Candida spp. in deep-seated infections from United States and some European Centers, although multidrug resistance rates above 10% are restricted to some US centers.Candida haemulonii complex isolates with poor susceptibility to azoles and amphotericin B have been isolated in superficial and deep-seated infections, whereas Candida guilliiermondii complex isolates with poor susceptibility to azoles and echinocandins have been recovered from catheter-related bloodstream infections. Other potential MDR Candida species are Candida krusei,Candida lusitaniae,Candida kefyr,Yarrowia(Candida)lypolitica,and Candida rugosa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Echinocandins were launched in the early 2000s and became the first-line treatment following the emergence of C. glabrata with reduced susceptibility to fluconazole Colombo et al. [101].”
From Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival (2021) · cites this paper as [101]
In the citing paper
“Mutations frequently occur in FKS2 relative to FKS1 [101].”
From Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival (2021) · cites this paper as [101]
In the citing paper
“The SENTRY surveillance program between 2006 and 2010 reported 11% echinocandin and fluconazole resistance among C. glabrata (i.e., MDR) [101].”
From Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival (2021) · cites this paper as [101]
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Self-citationSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Cornely, O. A., Arıkan-Akdağlı, S., Dannaoui, É., Groll, A. H., Lagrou, K., Chakrabarti, A., Lanternier, F., Pagano, L., Skiada, A., Akova, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12371 · Cited by 864
Self-citationAlexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768
Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Cited by
Sorted by citations
(BIOHAZ), E. P. O. B. H., Ricci, A., Allende, A., Bolton, D., Chemaly, M., Davies, R., Gironés, R., Herman, L., Koutsoumanis, K. P., Lindqvist, R., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4664 · Cited by 467
Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens
Friedman, D. Z. P., & Schwartz, I. S. (2019) · Journal of Fungi · doi:10.3390/jof5030067 · Cited by 369
(BIOHAZ), E. P. O. B. H., Koutsoumanis, K., Allende, A., Alvarez‐Ordóñez, A., Bolton, D., Bover‐Cid, S., Chemaly, M., Davies, R., De Cesare, A., Hilbert, F., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.5966 · Cited by 294
Ahmad, S., & Alfouzan, W. (2021) · Microorganisms · doi:10.3390/microorganisms9040807 · Cited by 269
Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival
Hassan, Y., Chew, S. Y., & Than, L. T. L. (2021) · Journal of Fungi · doi:10.3390/jof7080667 · Cited by 170
Candida auris Outbreaks: Current Status and Future Perspectives
Gaetano, S. D., Midiri, A., Mancuso, G., Avola, M. G., & Biondo, C. (2024) · Microorganisms · doi:10.3390/microorganisms12050927 · Cited by 117
Thomaz, D. Y., de Almeida, J. N., Sejas, O. N. E., Negro, G. M. B. D., Carvalho, G. O. M. H., Gimenes, V. M. F., de Souza, M. E. B., Arastehfar, A. A., Camargo, C. H., Motta, A. L., et al. (2021) · Journal of Fungi · doi:10.3390/jof7040259 · Cited by 100
Antifungal Resistance in Candida auris: Molecular Determinants
Frías-De-León, M. G., Hernández-Castro, R., Vite-Garín, T., Arenas, R., Bonifaz, A., Castañón-Olivares, L., Acosta-Altamirano, G., & Martínez-Herrera, E. (2020) · Antibiotics · doi:10.3390/antibiotics9090568 · Cited by 93
Strategies to Prevent Transmission of Candida auris in Healthcare Settings
Ahmad, S., & Asadzadeh, M. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00451-7 · Cited by 88
Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination
León, M. G. F.-D., Hernández‐Castro, R., Conde-Cuevas, E., García-Coronel, I. H., Vázquez-Aceituno, V. A., Soriano-Ursua, M. A., Farfán‐García, E. D., Ocharan-Hernández, M. E., Rodríguez‐Cerdeira, C., Arenas, R., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101529 · Cited by 85
Clements, T., Ndlovu, T., & Khan, W. (2019) · Microbiological Research · doi:10.1016/j.micres.2019.126329 · Cited by 77
Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 70
de Oliveira, H. C., Monteiro, M. C., Rossi, S. A., Pemán, J., Gaitán, A. C. R., Mendes‐Giannini, M. J. S., Mellado, E., & Zaragoza, Ó. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00083 · Cited by 68
Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
Wambaugh, M. A., Denham, S. T., Ayala, M., Brammer, B., Stonhill, M. A., & Brown, J. C. (2020) · eLife · doi:10.7554/elife.54160 · Cited by 65
“We also tested our combinations against common Candida species that often develop multi-drug resistance (Colombo et al., 2017), including the emerging MDR pathogen Candida auris (Figure 4).”
The effect of antifungal resistance development on the virulence of Candida species
Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 72
Screening the antifungal activities of monoterpenes and their isomers againstCandidaspecies
Iraji, A., Yazdanpanah, S., Alizadeh, F., Mirzamohammadi, S., Ghasemi, Y., Pakshir, K., Yang, Y., & Zomorodian, K. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14740 · Cited by 62
Padovan, A. C. B., Rocha, W. P. D. S., Toti, A. C. D. M., de Jesus, D. F. F., Chaves, G. M., & Colombo, A. L. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103267 · Cited by 55
Self-citationKhunweeraphong, N., & Kuchler, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094806 · Cited by 56
Chen, P.-Y., Chuang, Y.-C., Wu, U.-I., Sun, H.-Y., Wang, J.-T., Sheng, W.-H., Lo, H.-J., Wang, H.-Y., Chen, Y.-C., & Chang, S.-C. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190520 · Cited by 51
The epidemiology of Candida species in the Middle East and North Africa
Ghazi, S., Rafei, R., Osman, M., El Safadi, D., Mallat, H., Papon, N., Dabboussi, F., Bouchara, J.-P., & Hamze, M. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.006 · Cited by 50
Al-Baqsami, Z. F., Ahmad, S., & Khan, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-63240-z · Cited by 51
Bolous, M., Arumugam, N., Almansour, A. I., Kumar, R. S., Maruoka, K., Antharam, V. C., & Thangamani, S. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.022 · Cited by 48
Dudiuk, C., Berrío, I., Leonardelli, F., Morales-López, S. E., Theill, L., Macedo, D., Rodríguez, J. Y., Salcedo, S., Marín, A., Gamarra, S. P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz178 · Cited by 47
Mas, C. D., Rossato, L. L., Shimizu, T., Oliveira, E. B., da Silva, P. I., Meis, J. F. G. M., Colombo, A. L., & Hayashi, M. A. F. (2019) · Biomolecules · doi:10.3390/biom9060205 · Cited by 47
Self-citationShaw, T. D., Krasnodembskaya, A. D., Schroeder, G. N., Zumla, A. I., Maeurer, M. J., & O’Kane, C. M. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-21 · Cited by 43
Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health
de Oliveira, H. C., Bezerra, B. T., & Rodrigues, M. L. (2022) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.2c00055 · Cited by 42
Oliva, A., Rosa, F. G. D., Mikulska, M., Pea, F., Sanguinetti, M., Tascini, C., & Venditti, M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2240956 · Cited by 41
Menezes, R. D. P., Bessa, M. A. D. S., Siqueira, C. D. P., Teixeira, S. C., Ferro, E. A. V., Martins, M. M., Cunha, L. C. S., & Martins, C. H. G. (2022) · Antibiotics · doi:10.3390/antibiotics11091154 · Cited by 39
Retinoids in Fungal Infections: From Bench to Bedside
Cosio, T., Gaziano, R., Zuccari, G., Costanza, G., Grelli, S., Francesco, P. D., Bianchi, L., & Campione, E. (2021) · Pharmaceuticals · doi:10.3390/ph14100962 · Cited by 38
Antifungal susceptibility profiles of rare ascomycetous yeasts
Hansen, A. P., Lass‐Flörl, C., Lackner, M., Rare Yeast Study Group, Aigner, M., Alastruey‐Izquierdo, A., Arıkan-Akdağlı, S., Bader, O., Becker, K., Boekhout, T., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz231 · Cited by 41
Self-citationBenzimidazole tethered pyrrolo[3,4-b]quinoline with broad-spectrum activity against fungal pathogens
Villa, P., Arumugam, N., Almansour, A. I., Kumar, R. S., Mahalingam, S. M., Maruoka, K., & Thangamani, S. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.01.006 · Cited by 37
Dantas-Medeiros, R., Zanatta, A. C., de Souza, L. B. F. C., Fernandes, J. M., Amorim-Carmo, B., Torres-Rêgo, M., Fernandes‐Pedrosa, M. D. F., Vilegas, W., Araújo, T. A. D. S., Michel, S., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.613155 · Cited by 36
How urgent is the need for new antifungals?
Stewart, A. G., & Paterson, D. L. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1935868 · Cited by 36
Díaz-García, J., Gómez, A., Machado, M., Alcalá, L., Reigadas, E., Sánchez-Carrillo, C., Pérez-Ayala, A., Gómez-García De La Pedrosa, E., González-Romo, F., Cuétara, M. S., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac288 · Cited by 35
Self-citationLima, S. L., Francisco, E. C., de Almeida, J. N., Santos, D. W. D. C. L., Carlesse, F., Queiroz‐Telles, F., Melo, A. S. D. A., & Colombo, A. L. (2020) · Journal of Fungi · doi:10.3390/jof6030110 · Cited by 34
Self-citationCandida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity
Ahmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W. A., Joseph, L., & Asadzadeh, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240426 · Cited by 33
Marino, A., Nostro, A., Mandras, N., Roana, J., Ginestra, G., Miceli, N., Taviano, M. F., Gelmini, F., Beretta, G., & Tullio, V. C. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2877-x · Cited by 32
Nguyen, T. N. Y., Padungros, P., Wongsrisupphakul, P., Sa‐Ard‐Iam, N., Mahanonda, R., Matangkasombut, O., Choo, M., & Ritprajak, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-35101-3 · Cited by 30
D’Arrigo, M., Bisignano, C., Irrera, P., Smeriglio, A., Zagami, R., Trombetta, D., Romeo, O., & Mandalari, G. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2425-0 · Cited by 30
Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections
Campos, L. D. A., Fin, M. T., dos Santos, K. S., Gualque, M. W. D. L., Cabral, A. K. L. F., Khalil, N. M., Fusco‐Almeida, A. M., Mainardes, R. M., & Mendes‐Giannini, M. J. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010266 · Cited by 29
Methods for identification of Candida auris, the yeast of global public health concern: A review
Mahmoudi, S., Afshari, S. A. K., Gharehbolagh, S. A., Mirhendi, H., & Makimura, K. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.04.004 · Cited by 29
Candida glabrata is a successful pathogen: An artist manipulating the immune response
Castrejón-Jiménez, N. S., Castillo-Cruz, J., Baltierra‐Uribe, S. L., Hernández-González, J. C., & Estela, G.-P. B. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127038 · Cited by 35
Thiyahuddin, N. M., Lamping, E., Rich, A. M., & Cannon, R. D. (2019) · Journal of Fungi · doi:10.3390/jof5020030 · Cited by 28
Rodrigues, L. S., Motta, F. D. A., Picharski, G. L., Vasconcelos, T. M., Ricieri, M. C., & Dalla-Costa, L. M. (2019) · Medicine · doi:10.1097/md.0000000000015933 · Cited by 28
Silva, L. N., de Mello, T. P., Ramos, L. S., Branquinha, M. H., & dos Santos, A. L. S. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191025152412 · Cited by 27
Navarro-Muñoz, J. C., de Jong, A. W., van den Ende, B. G., Haas, P., Then, E., Tap, R. M., Collemare, J., & Hagen, F. (2019) · Mycopathologia · doi:10.1007/s11046-019-00404-0 · Cited by 27
Essghaier, B., Dridi, R., Arouri, A., & Zid, M. F. (2021) · Polyhedron · doi:10.1016/j.poly.2021.115420 · Cited by 26
Yarrowia lipolytica causes sporadic cases and local outbreaks of infections and colonisation
Desnos‐Ollivier, M., Letscher‐Bru, V., Neuvéglise, C., & Dromer, F. (2020) · Mycoses · doi:10.1111/myc.13095 · Cited by 25
Potente, G., Bonvicini, F., Gentilomi, G. A., & Antognoni, F. (2020) · Antibiotics · doi:10.3390/antibiotics9070395 · Cited by 27
Insights into the Multi-Azole Resistance Profile in Candida haemulonii Species Complex
Silva, L. N., Ramos, L. S., de Oliveira, S. S. C., Magalhães, L. B., Squizani, E. D., Kmetzsch, L., Vainstein, M. H., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Journal of Fungi · doi:10.3390/jof6040215 · Cited by 27
Teke, L., Barış, A., & Bayraktar, B. (2021) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2021.106232 · Cited by 25
Tseng, K., Chen, Y.-Z., Zhou, Z.-L., Tsai, J., Tseng, M.-N., Liu, H.-L., Wu, C., Liao, Y.-C., Lin, C.-C., Tsai, D.-J., et al. (2024) · Emerging infectious diseases · doi:10.3201/eid3011.240545 · Cited by 24
Superficial candidosis by Candida duobushaemulonii: An emerging microorganism
León, M. G. F.-D., Martínez-Herrera, E. O., Acosta‐Altamirano, G., Arenas, R. G., & Rodríguez‐Cerdeira, C. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.103960 · Cited by 24
Yeast communities of primary and secondary peat swamp forests in southern Thailand
Boonmak, C., Khunnamwong, P., & Limtong, S. (2019) · Antonie van Leeuwenhoek · doi:10.1007/s10482-019-01317-0 · Cited by 23
Limtong, S., Am-In, S., Kaewwichian, R., Kaewkrajay, C., & Jindamorakot, S. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01479-2 · Cited by 22
Araújo, J. M. M., Monteiro, J. D. M., Silva, D. H. D. S., Alencar, A., Silva, K., Coelho, L., Pachêco, W. B., da Silva, D. F., Silva, M. J., da Silva, L. C. N., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11081106 · Cited by 24
Spiliopoulou, A., Kolonitsiou, F., Vrioni, G., Tsoupra, S., Lekkou, A., & Paliogianni, F. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101236 · Cited by 21
Lima, S. L., Rossato, L. L., & Melo, A. S. D. A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104461 · Cited by 20
Pietrobom, P. M. P., & Colombo, A. L. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000684 · Cited by 20
Self-citationStringaro, A., Colone, M., Cecchetti, S., Zeppetella, E., Spadaro, F., & Angiolella, L. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03355-1 · Cited by 19
Antimicrobial Activity of 4-Chlorocinnamic Acid Derivatives
Silva, R. H. N., Andrade, A. C. M., Nóbrega, D. F., de Castro, R. D., Pessôa, H. L. F., Rani, N., & de Sousa, D. P. (2019) · BioMed Research International · doi:10.1155/2019/3941242 · Cited by 19
Quiles‐Melero, I., & García‐Rodríguez, J. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2021.04.004 · Cited by 18
Candida haemulonii Species Complex: A Mini-review
Francisco, E. C., de Jong, A. W., & Colombo, A. L. (2023) · Mycopathologia · doi:10.1007/s11046-023-00748-8 · Cited by 18
Self-citationHamburger, F. G., Gales, A. C., & Colombo, A. L. (2024) · Mycopathologia · doi:10.1007/s11046-024-00867-w · Cited by 19
Self-citationTome, M., Zupan, J., Tomičić, Z., Matos, T., & Raspor, P. (2018) · PeerJ · doi:10.7717/peerj.4999 · Cited by 18
Yano, J., Yu, A., Fidel, P. L., & Noverr, M. C. (2019) · mSphere · doi:10.1128/msphere.00191-19 · Cited by 18
da Silva, L. J., Barroso, F. D. D., Vieira, L. S., Mota, D. R. C., Firmino, B. K. D. S., da Silva, C. R., Cabral, V. P. D. F., Cândido, T. M., Sá, L. G. D. A. V., da Silva, W. M. B., et al. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001308 · Cited by 17
Microscopic fungi on the corpse – Promising tool requiring further research
Spychała, K., Piecuch, A., Szleszkowski, Ł., Kadej, M., & Ogórek, R. (2024) · Forensic Science International · doi:10.1016/j.forsciint.2024.112129 · Cited by 16
Zuzarte, M., Correia, P. M. P., Alves-Silva, J. M., Gonçalves, M. J., Cavaleiro, C., Cruz, M. T., & Salgueiro, L. (2021) · Antibiotics · doi:10.3390/antibiotics10050592 · Cited by 16
Alves-Silva, J. M., Gonçalves, M. J., da Silva, A. B. G., Cavaleiro, C., Cruz, M. T., & Salgueiro, L. (2023) · Antibiotics · doi:10.3390/antibiotics12010179 · Cited by 16
Galocha, M., Viana, R., Pais, P., Silva-Dias, A., Cavalheiro, M., Miranda, I. M., Ende, M. V., Souza, C. S., Costa, C., Branco, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04087-0 · Cited by 15
Francisco, E. C., Cáceres, D. H., Brunelli, J. G. P., García‐Effrón, G., Arastehfar, A. A., Ribeiro, F. D. C., Almeida, M. N. D., Gonçalves, S. S., de Almeida, J. N., Lass‐Flörl, C., et al. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-23 · Cited by 15
Self-citationRole of lizards as reservoirs of pathogenic yeasts of zoonotic concern
Rhimi, W., Mendoza‐Roldan, J. A., Aneke, C. I., Mosca, A., Otranto, D., Alastruey‐Izquierdo, A., & Cafarchia, C. (2022) · Acta Tropica · doi:10.1016/j.actatropica.2022.106472 · Cited by 15
Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
Scavello, F., Mutschler, A., Hellé, S., Schneider, F., Chasserot‐Golaz, S., Strub, J., Cianférani, S., Haïkel, Y., & Metz‐Boutigue, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-94749-6 · Cited by 15
Montoya, A. M., Luna-Rodríguez, C. E., Gracia-Robles, G., Rojas, O. C., Treviño‐Rangel, R. D. J., & González, G. M. (2019) · Mycologia · doi:10.1080/00275514.2019.1585161 · Cited by 14
Ganan, M., Lorentzen, S. B., Gaustad, P., & Sørlie, M. (2021) · Journal of Fungi · doi:10.3390/jof7090718 · Cited by 14
Social, environmental and microbiologic aspects of endemic mycoses in Brazil
da Costa, M. C., de Sá, N. P., Johann, S., & Santos, D. A. (2019) · New Microbes and New Infections · doi:10.1016/j.nmni.2018.11.004 · Cited by 14
Opportunistic infections in pediatrics: when to suspect and how to approach
de Moraes‐Pinto, M. I., & Ferrarini, M. A. G. (2019) · Jornal de Pediatria · doi:10.1016/j.jped.2019.09.008 · Cited by 15
Molecular Diagnostic Advances in Transplant Infectious Diseases
Young, B. A., Hanson, K. E., & Gómez, C. A. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0704-7 · Cited by 14
Fruits are vehicles of drug-resistant pathogenic Candida tropicalis
Chen, Y.-Z., Tseng, K., Wang, S., Huang, C.-L., Lin, C.-C., Zhou, Z.-L., Tsai, D.-J., Lin, C.-M., Chen, Y.-L., Chen, K.-T., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01471-23 · Cited by 13
Wang, Y., Xu, J., Abid, F. B., Salah, H., Sundararaju, S., Ismail, K. A., Wang, K., Matthew, L. S., Taj‐Aldeen, S. J., Ibrahim, E. B., et al. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001179 · Cited by 13
Mao, Z., Deng, A., Jin, X., Zhou, T., Zhang, S., Li, M., Lv, W., Huang, L., Zhong, H., Wang, S., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04265 · Cited by 13
Dinh, T. T. H., Tummamunkong, P., Padungros, P., Ponpakdee, P., Boonprakong, L., Saisorn, W., Leelahavanichkul, A., Kueanjinda, P., & Ritprajak, P. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.566661 · Cited by 13
Faletrov, Y. V., Efimova, V. S., Horetski, M. S., Tugaeva, K. V., Frolova, N. S., Lin, Q., Isaeva, L. V., Rubtsov, M. A., Sluchanko, N. N., Novikova, L. A., et al. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.104850 · Cited by 11
Multiplex size marker (YEAST PLEX) for rapid and accurate identification of pathogenic yeasts
Aboutalebian, S., Mahmoudi, S., Charsizadeh, A., Nikmanesh, B., Rizi, M. H., & Mirhendi, H. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24370 · Cited by 11
de Souza, P. C., Corrêa, A. E. D. N., Gameiro, J. G., de Oliveira, A. G., Panagio, L. A., Venâncio, E. J., & Almeida, R. S. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106166 · Cited by 11
Existing and emerging therapies for the treatment of invasive candidiasis and candidemia
Bels, D. D., Maillart, E., Françoise Van Bambeke, A., Redant, S., & Honoré, P. M. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2142207 · Cited by 12
Kręgiel, D., Czarnecka, K. H., Schusterová, H., Vadkertiová, R., & Nowak, A. (2023) · Molecules · doi:10.3390/molecules28135064 · Cited by 11
Chiang, T. T.-K., Shtein, R. M., McCoy, K. E., Hurlbert, S., & Grossman, G. (2019) · Cornea · doi:10.1097/ico.0000000000002242 · Cited by 11
Detection and Control of Fungal Outbreaks
Caceres, D. H., Tap, R. M., Alastruey‐Izquierdo, A., & Hagen, F. (2020) · Mycopathologia · doi:10.1007/s11046-020-00494-1 · Cited by 11
A Comprehensive Review of Identification Methods for Pathogenic Yeasts: Challenges and Approaches
Morovati, H., Kord, M., Ahmadikia, K., Eslami, S., Hemmatzadeh, M., Kurdestani, K. M., Khademi, M., & Darabian, S. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_375_22 · Cited by 10
Ahmad, S., Boekhout, T., Al‐Hatmi, A. M. S., Al‐Harrasi, A., Khateb, A. M., Dhaheri, F. A. A., Shuraym, H. B., Thomsen, J., Alobaid, K., Asadzadeh, M., et al. (2025) · Mycoses · doi:10.1111/myc.70073 · Cited by 10
da Cruz, J. E. R., Saldanha, H. C., Freitas, G. R. O. E., & Morais, E. R. (2021) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2021.100523 · Cited by 11
Dutra, J. A. P., Maximino, S. C., Gonçalves, R. D. C. R., Morais, P. A. B., Silva, W. C. D. L., Rodrigues, R. P., Neto, Á. C., Lacerda, V., Borges, W. D. S., & Kitagawa, R. R. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14131 · Cited by 10
Maliszewska, I. H., Wawrzyńczyk, D., & Wanarska, E. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2019.101623 · Cited by 10
Guerra, R. N. M., Oliveira, A. D. S., Farias, J. R., Franco, D. C. G., Santos, P. G., Barbosa, N. T., Muniz, S. B., Abreu, A. G., & do Nascimento, F. R. F. (2025) · Antibiotics · doi:10.3390/antibiotics14030308 · Cited by 9
Pilařová, V., Vlčková, H., Jung, O., Protti, M., Buchta, V., Mercolini, L., Švec, F., & Nováková, L. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02699-1 · Cited by 9
A brief review on heterocyclic compounds with promising antifungal activity against Candida species
Korol', �. N., Molnar-babilya, D., Slivka, M. V., & Onysko, M. Y. (2022) · Organic Communications · doi:10.25135/acg.oc.141.2210.2609 · Cited by 9
Susceptibility of uncommon Candida species to systemic antifungals by the EUCAST methodology
Díaz-García, J., Alcalá, L., Martín‐Rabadán, P., Mesquida, A., Sánchez‐Carrillo, C., Reigadas, E., Muñóz, P., Escribano, P., & Guinea, J. (2019) · Medical Mycology · doi:10.1093/mmy/myz121 · Cited by 9
Self-citationLiver abscess caused by Candida haemulonii var. vulnera. First case report in Peru
Pérez‐Lazo, G., Morales-Moreno, A., Soto‐Febres, F., Hidalgo, J. A. M., Neyra, E., & Bustamante, B. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.12.001 · Cited by 8
Metadata
- Authors
- Colombo, A. L., Júnior, J. N. D. A., & Guinea, J.
- Affiliations
- Universidade Federal de São Paulo (BR)
- Central Laboratory Division (LIM03), Laboratory of Medical Mycology (LIM53), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
- Medicine Department, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Corresponding author
- Colombo, Arnaldo L.
- ORCID
- Colombo, Arnaldo L.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2017-12
- Volume
- 30
- Issue
- 6
- Pages
- 528-538
- ISSN
- 0951-7375 (ISSN-L)
- 1473-6527
- OpenAlex
- W2765742851
- Semantic Scholar
- e4e3cc325bd6f2e43de0c05a4f19c50193ddf27c
- Cited by
- 177
- References
- 136
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 18 · 2023: 30 · 2022: 23 · 2021: 27 · 2020: 20 · 2019: 31 · 2018: 3 · 2017: 2
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- Candida auris, Candida glabrata, Candida krusei, Candida lusitaniae, Candida kefyr, Candida rugosa, invasive candidiasis, candidemia, azole resistance, echinocandin resistance, amphotericin B resistance, horizontal transmission, early detection, clinical management, catheter-related bloodstream infection
- MeSH terms
- Antifungal Agents, Candida, Candidiasis, Humans, Communicable Diseases, Emerging, Drug Resistance, Multiple, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review